New Zealand's science-led response to the SARS-CoV-2 pandemic.

Geoghegan, Jemma L; Moreland, Nicole J; Le Gros, Graham; Ussher, James E

Geoghegan, Jemma L; Moreland, Nicole J; Le Gros, Graham; Ussher, James E.

Geoghegan JL; Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
Moreland NJ; Institute of Environmental Science and Research, Wellington, New Zealand.
Le Gros G; Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland, New Zealand.
Ussher JE; Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland, New Zealand.

Nat Immunol ; 22(3): 262-263, 2021 03.

Article in English | MEDLINE | ID: covidwho-1101663

Subject(s)

COVID-19/epidemiology; Communicable Disease Control; Public Health; Public Policy; Advisory Committees; COVID-19/prevention & control; COVID-19/transmission; COVID-19 Vaccines/therapeutic use; Communicable Diseases, Imported; Disease Transmission, Infectious; Emigration and Immigration; Humans; Mass Screening; New Zealand/epidemiology; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Public Policy / Communicable Disease Control / Public Health / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Humans Country/Region as subject: Oceania Language: English Journal: Nat Immunol Journal subject: Allergy and Immunology Year: 2021 Document Type: Article Affiliation country: S41590-021-00872-x

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google